Work

Creating and evaluating genetic tests predictive of drug response

Year: 2008

Type: review

Source: Nature Reviews Drug Discovery

DOI: 10.1038/nrd2520

Authors: Scott T. Weiss, Howard L. McLeod, David A. Flockhart, M. Eileen Dolan, Neal L. Benowitz, Julie A. Johnson, Mark J. Ratain, Kathleen M. Giacomini

Institutions: Brigham and Women's Hospital, Harvard University, University of North Carolina at Chapel Hill, Sidney & Lois Eskenazi Hospital, Indiana University School of Medicine, University of Chicago, University of California, San Francisco, University of Florida

Language: English

Topic: Pharmacogenetics and Drug Metabolism

Subfield: Pharmacology

Field: Pharmacology, Toxicology and Pharmaceutics

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: green

Funders: National Heart, Lung, and Blood Institute, National Institute on Drug Abuse, National Institute of General Medical Sciences

Awards: G1036496709, G1132902772, G187421119, G291751459, G3974200394, G3990411403, G4277768125, G466213475, PAAR-Pharmacogenomics of Anticancer Agents Research Group, Pharmacogenetics of Nicotine Addiction Treatment, Pharmacogenetics of Membrane Transporters, G923911029

OpenAlex ID: W2019464839

FWCI: 1.829

Cites: 32

Cited by: 54

Related to: 10